JP2023509798A5 - - Google Patents
Info
- Publication number
- JP2023509798A5 JP2023509798A5 JP2022542380A JP2022542380A JP2023509798A5 JP 2023509798 A5 JP2023509798 A5 JP 2023509798A5 JP 2022542380 A JP2022542380 A JP 2022542380A JP 2022542380 A JP2022542380 A JP 2022542380A JP 2023509798 A5 JP2023509798 A5 JP 2023509798A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- disorder
- neuroactive steroid
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062959977P | 2020-01-12 | 2020-01-12 | |
| US62/959,977 | 2020-01-12 | ||
| PCT/US2021/013112 WO2021142477A1 (en) | 2020-01-12 | 2021-01-12 | Neuroactive steroids and pharmaceutical composition containing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023509798A JP2023509798A (ja) | 2023-03-09 |
| JP2023509798A5 true JP2023509798A5 (enExample) | 2024-01-19 |
Family
ID=76788885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542380A Pending JP2023509798A (ja) | 2020-01-12 | 2021-01-12 | ニューロアクティブステロイド、及びニューロアクティブステロイドを含む医薬組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230118577A1 (enExample) |
| EP (1) | EP4087854A4 (enExample) |
| JP (1) | JP2023509798A (enExample) |
| KR (1) | KR20230031812A (enExample) |
| CN (1) | CN115244065B (enExample) |
| AU (1) | AU2021206712A1 (enExample) |
| BR (1) | BR112022013585A2 (enExample) |
| CA (1) | CA3167331A1 (enExample) |
| IL (1) | IL294606A (enExample) |
| MX (1) | MX2022008614A (enExample) |
| WO (1) | WO2021142477A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021013695A (es) | 2019-05-10 | 2022-01-26 | Brii Biosciences Inc | Composición farmacéutica que contiene brexanolona, ganaxolona y zuranolona y usos de esta. |
| SG11202112391UA (en) * | 2019-05-31 | 2021-12-30 | Sage Therapeutics Inc | Neuroactive steroids and compositions thereof |
| WO2021188778A2 (en) * | 2020-03-18 | 2021-09-23 | Sage Therapeutics, Inc. | Neuroactive steroids and their methods of use |
| CN115974950A (zh) * | 2022-12-23 | 2023-04-18 | 上海彩迩文生化科技有限公司 | 一种3-烷基化的甾体中间体及其制备和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1359646A (fr) * | 1962-11-22 | 1964-04-30 | Roussel Uclaf | Procédé de préparation de dérivés stéroïdes et produits obtenus par ce procédé |
| NL6808141A (enExample) * | 1967-06-16 | 1968-12-17 | ||
| GB1409239A (en) * | 1971-11-11 | 1975-10-08 | Glaxo Lab Ltd | Process for the preparation of 3alpha-hydroxy-5alpha-steroids |
| KR20240157128A (ko) * | 2016-03-08 | 2024-10-31 | 세이지 테라퓨틱스, 인크. | 신경활성 스테로이드, 조성물, 및 그의 용도 |
| MA45599A (fr) * | 2016-07-11 | 2019-05-15 | Sage Therapeutics Inc | Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation |
| SG11202112391UA (en) * | 2019-05-31 | 2021-12-30 | Sage Therapeutics Inc | Neuroactive steroids and compositions thereof |
| IL295902A (en) * | 2020-02-27 | 2022-10-01 | Brii Biosciences Inc | Drug inhibitors of neuroactive steroids |
-
2021
- 2021-01-12 IL IL294606A patent/IL294606A/en unknown
- 2021-01-12 KR KR1020227027899A patent/KR20230031812A/ko active Pending
- 2021-01-12 JP JP2022542380A patent/JP2023509798A/ja active Pending
- 2021-01-12 CA CA3167331A patent/CA3167331A1/en active Pending
- 2021-01-12 MX MX2022008614A patent/MX2022008614A/es unknown
- 2021-01-12 EP EP21738878.4A patent/EP4087854A4/en active Pending
- 2021-01-12 WO PCT/US2021/013112 patent/WO2021142477A1/en not_active Ceased
- 2021-01-12 AU AU2021206712A patent/AU2021206712A1/en active Pending
- 2021-01-12 US US17/792,319 patent/US20230118577A1/en not_active Abandoned
- 2021-01-12 BR BR112022013585A patent/BR112022013585A2/pt unknown
- 2021-01-12 CN CN202180020110.2A patent/CN115244065B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023509798A5 (enExample) | ||
| JP2021519267A5 (enExample) | ||
| JP2017531020A5 (enExample) | ||
| JP2018508592A5 (enExample) | ||
| JP2023539125A5 (enExample) | ||
| JP2018505898A5 (enExample) | ||
| RU2015143466A (ru) | Нейроактивные стероиды и способы их применения | |
| JP2022513933A5 (enExample) | ||
| JP2014526469A5 (enExample) | ||
| JP2022515766A5 (enExample) | ||
| JP2012510437A5 (enExample) | ||
| JP2019520416A5 (enExample) | ||
| RU2016131875A (ru) | Производные n-фениллактама, способные стимулировать нейрогенез, и их применение при лечении заболеваний нервной системы | |
| RU2012127770A (ru) | Полициклические соединения и способы их применения | |
| JP2009527462A5 (enExample) | ||
| JP2014505690A5 (enExample) | ||
| RU2018140250A (ru) | Пролекарство производного аминокислоты | |
| RU2015104056A (ru) | Ингибиторы фермента фосфодиэстеразы 10 | |
| RU2016104890A (ru) | Производные 1,7-нафтиридина | |
| BR112015027362A2 (pt) | derivados de isoquinolina estimulantes de neurogênese | |
| JP2023507569A5 (enExample) | ||
| AR079103A1 (es) | Compuesto de sal de mesilato de (s) -2-(4-(3-fluoro-benciloxi)-bencilamino)-propionamida, forma polimorfica (nf6) , composicion farmaceutica, uso del mismo para la preparacion de un medicamento y su procesos de preparacion | |
| JP2019532983A5 (enExample) | ||
| JP2017502069A5 (enExample) | ||
| RU2016132574A (ru) | Органические соединения |